| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/22/1998 | CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
| 10/22/1998 | CA2286594A1 Plants with controlled side-shoot formation and/or controlled abscission area formation |
| 10/22/1998 | CA2286484A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 10/22/1998 | CA2286478A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 10/22/1998 | CA2286461A1 Controlled dissolution cross-linked protein crystals |
| 10/22/1998 | CA2286351A1 Extracellular/epidermal growth factor like protein |
| 10/22/1998 | CA2286332A1 Inhibitors for urokinase receptor |
| 10/22/1998 | CA2286327A1 A nitrobenzylmercaptopurineriboside (nbmpr)-insensitive, equilibrative, nucleoside transport protein, nucleic acids encoding the same and methods of use |
| 10/22/1998 | CA2286290A1 Secreted proteins and polynucleotides encoding them |
| 10/22/1998 | CA2286262A1 Apparatus and method for automated protein design |
| 10/22/1998 | CA2284127A1 Flt3 ligand chimeric proteins |
| 10/22/1998 | CA2283750A1 Oxidative stress resistance gene |
| 10/22/1998 | CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
| 10/22/1998 | CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor |
| 10/22/1998 | CA2229428A1 3-dehydroquinate synthase (arob) |
| 10/21/1998 | EP0872557A1 Neutrophil chemotactic lymphokine, and drug and kit for the diagnosis of drug hypersensitive granulocytopenia containing the same |
| 10/21/1998 | EP0872555A1 Bacterial peptide library |
| 10/21/1998 | EP0872553A1 Chimeric and/or growth-restricted flaviviruses |
| 10/21/1998 | EP0872552A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or Apoptin |
| 10/21/1998 | EP0872551A2 Alteration of plant morphology by control of profilin expression |
| 10/21/1998 | EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor |
| 10/21/1998 | EP0872487A2 Preparation of recombinant factor VIII in a protein free medium |
| 10/21/1998 | EP0872486A1 Eimeria proteins as vaccines |
| 10/21/1998 | EP0871885A1 Attachment enhanced 293 cells |
| 10/21/1998 | EP0871883A1 Compounds and methods related to parathyroid hormone-like protein |
| 10/21/1998 | EP0871779A2 Compositions and methods for diagnosis of mutation in the von hippel-lindau tumor suppressor gene |
| 10/21/1998 | EP0871776A1 A novel human b cell surface molecule |
| 10/21/1998 | EP0871765A1 Determination of cancerous conditions by mage gene expression |
| 10/21/1998 | EP0871763A1 Method for preparation of type ii collagen |
| 10/21/1998 | EP0871762A1 Hp-8 autoantigen |
| 10/21/1998 | EP0871757A1 Conditionally replicating viral vectors and their use |
| 10/21/1998 | EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
| 10/21/1998 | EP0871755A1 Vectors for gene delivery |
| 10/21/1998 | EP0871752A1 Root specific promoters |
| 10/21/1998 | EP0871751A1 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 10/21/1998 | EP0871749A1 Oil body proteins as carriers of high value proteins |
| 10/21/1998 | EP0871748A2 Delivery of biologically active polypeptides |
| 10/21/1998 | EP0871741A1 Novel expression vectors for production of foreign proteins as soluble forms |
| 10/21/1998 | EP0871740A1 Papaya ringspot virus coat protein gene |
| 10/21/1998 | EP0871739A1 Plants resistant to c strains of cucumber mosaic virus |
| 10/21/1998 | EP0871738A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 10/21/1998 | EP0871737A1 Method of protecting crop plants against insect pests |
| 10/21/1998 | EP0871736A2 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
| 10/21/1998 | EP0871735A1 Therapeutic and diagnostic compositions |
| 10/21/1998 | EP0871734A1 Polypeptide fragments capable of competition with streptococcus mutans antigen i/ii |
| 10/21/1998 | EP0871733A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 10/21/1998 | EP0871732A1 Method of treating sepsis |
| 10/21/1998 | EP0871731A2 Antibodies for the control of cyst nematodes and transgenic plants expressing them |
| 10/21/1998 | EP0871730A1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 10/21/1998 | EP0871729A1 Steroid receptor coactivator compositions and methods of use |
| 10/21/1998 | EP0871728A2 Targets for breast cancer diagnosis and treatment |
| 10/21/1998 | EP0871727A2 Neuron-restrictive silencer factor proteins |
| 10/21/1998 | EP0871726A1 Multispecific chimeric receptors |
| 10/21/1998 | EP0871725A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 10/21/1998 | EP0871724A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus |
| 10/21/1998 | EP0871723A1 Somatic gene therapy to cells associated with fluid spaces |
| 10/21/1998 | EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
| 10/21/1998 | EP0871720A2 Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition |
| 10/21/1998 | EP0871718A1 Production of enzymatically active recombinant carboxypeptidase b |
| 10/21/1998 | EP0871714A1 Method for solubilizing proteins in organic solvents |
| 10/21/1998 | EP0871711A1 Compositions and methods for site-directed integration into dna |
| 10/21/1998 | EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 10/21/1998 | EP0871708A1 Recombinant sweet protein mabinlin |
| 10/21/1998 | EP0871706A1 Stabilization of blood platelets against low temperature activation |
| 10/21/1998 | EP0871705A1 Human ccn-like growth factor |
| 10/21/1998 | EP0871704A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 10/21/1998 | EP0871703A1 Dna encoding glutamate gated chloride channels |
| 10/21/1998 | EP0871702A1 Cytokine designated lerk-7 |
| 10/21/1998 | EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 10/21/1998 | EP0871671A1 Purification of alpha-1 proteinase inhibitor |
| 10/21/1998 | EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 10/21/1998 | EP0871669A1 Human somatostatin-like receptor |
| 10/21/1998 | EP0871668A1 Human g-protein receptor hibef51 |
| 10/21/1998 | EP0871667A1 G-protein coupled receptor |
| 10/21/1998 | EP0871666A1 Receptor-selective somatostatin analogs |
| 10/21/1998 | EP0871665A1 Insulin derivatives |
| 10/21/1998 | EP0871664A1 Novel chemokine for mobilizing stem cells |
| 10/21/1998 | EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 10/21/1998 | EP0871662A1 Product derived from milk substantially free of beta casein from non-human mammals and relative use |
| 10/21/1998 | EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins |
| 10/21/1998 | EP0871660A1 A 12-kda protein derived from m. tuberculosis useful for treatment of autoimmune diseases |
| 10/21/1998 | EP0871659A1 Fusion proteins comprising cell cycle regulatory proteins |
| 10/21/1998 | EP0871658A2 Modified avidin and streptavidin molecules and use thereof |
| 10/21/1998 | EP0871657A1 Methods for treatment and prevention of diabetes |
| 10/21/1998 | EP0871655A2 Pcna binding substance |
| 10/21/1998 | EP0871652A1 Method for refolding insoluble aggregates of hepatitis c virus protease |
| 10/21/1998 | EP0871649A1 Conjugates of a polypeptide and a biocompatible polymer |
| 10/21/1998 | EP0871645A1 Modulators of the function of fas/apo1 receptors |
| 10/21/1998 | EP0871644A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 10/21/1998 | EP0871641A1 Multiple administrations of anti-tnf antibody |
| 10/21/1998 | EP0871495A1 Redirection of cellular immunity by receptor chimeras |
| 10/21/1998 | EP0871492A2 Mesothelium antigen and methods and kits for targeting it |
| 10/21/1998 | EP0871486A1 Diphtheria toxin epitopes |
| 10/21/1998 | EP0871482A1 Recombinant vesiculoviruses and their uses |
| 10/21/1998 | EP0871481A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 10/21/1998 | EP0871480A1 T cells mediating an immune response and methods of use |
| 10/21/1998 | EP0871477A1 Method for obtaining receptor agonist antibodies |
| 10/21/1998 | EP0871475A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 10/21/1998 | EP0871474A1 Generation of human insulin |
| 10/21/1998 | EP0871470A1 Haemopoietic growth factor antagonists and uses therefor |